Osteoporosis in postmenopausal women

How effective are bisphosphonates and denosumab for preventing fractures in postmenopausal women? Bisphosphonates and denosumab are similarly effective. Over 1 to 4 years, bisphosphonates or denosumab provide an absolute reduction of about 0.5% to 1.0% for hip fractures, 1.5% to 3% for